INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets
Accumulated Amortization	$ (333,414)	$ (384,712)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	4,789,144	4,477,391
Net Amount	4,455,730	4,092,679
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,967,124	1,855,279
Net Amount	1,967,124	1,855,279
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	270,753	264,289
Net Amount	270,753	264,289
Domestic Utilty Patent - Opera Software [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(10,983)	(10,484)
Net Amount	$ 20,968	$ 21,467
Weighted average remaining amortization period	10 years 6 months	10 years 9 months
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 2,519,316	$ 2,234,129
Accumulated Amortization	(322,431)	(282,485)
Net Amount	$ 2,196,885	$ 1,951,644
Weighted average remaining amortization period	13 years 9 months	14 years
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount		$ 91,743
Accumulated Amortization		$ (91,743)